诺和诺德股价因阿尔茨海默症药物semaglutide两项试验失败而暴跌8%
Novo shares tumble after 2 trial misses for semaglutide in Alzheimer's disease
生物技术与制药领域的最新动态
Novo shares tumble after 2 trial misses for semaglutide in Alzheimer's disease
'People are getting used to it': Global uncertainties can't dampen upbeat Jefferies conference
Bayer's asundexian cuts stroke risk in phase 3, reviving hopes for FXIa class
Sarepta shares positive safety update on DM1 asset as Arrowhead snares $200M milestone
Solventum to buy Acera Surgical for up to $850M, repurchase $1B in stock
J&J MedTech bolsters stroke R&D programs in Ireland
How COVAX raced to protect the world from COVID-19
The apple of my eye: How I’ve created a plant-health tracker for farmers in Tanzania
Beyond growth — why we need to agree on an alternative to GDP now
Introducing the j-metric: a true measure of what matters in academia
Fall-prevention clinical trial in rural China shows promising results
Daily briefing: This enigmatic figure reveals a common ancient myth
AI has a democracy problem — here’s why
Measles makes a comeback: four charts show where and how
Honouring visionary scientist and Nature’s founder, Norman Lockyer
Fishing around offshore wind farms could boost both conservation and green energy
Google DeepMind won a Nobel prize for AI: can it produce the next big breakthrough?
The UK must not lose its focus on science and innovation
Nations at COP30 must cancel fossil-fuel concessions to keep the Paris agreement in reach
Leaders at COP30 should promote solar and wind power over mega-dams